EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT EYEPOINT PHARMACEUTICALS, INC.

EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT)
Listen to this Section


$11.89
-0.3750 ( -3.06% ) 323.8K

EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.

Market Data


Open $11.89
Previous Close $12.26
Volume 323.8K
Market Cap $1.03B
Day Range $11.82 - $12.45
52 Week Range $7.94 - $19.11
Shares Outstanding 83.84M
Change % -3.06%
Net Change ▼ -0.3750
Insider Ownership -0.01%
Exchange NASDAQ
SectorMiscellaneous
IndustryNone
IPO Year2005
CountryUnited States

Insider Ownership Transactions

Total Amount Purchased: -1,310,968.00

Date Type Amount Purchased Purchaser
2024-07-12 Sale -2000.00 Zaderej Karen L.
2024-06-25 Sale -2000.00 ADAMIS ANTHONY P
2024-06-04 Sale -6525.00 GUYER DAVID R
2024-02-05 Sale -209.00 Jones David Scott
2024-01-30 Sale -15609.00 Paggiarino Dario A.
2024-01-29 Sale -9604.00 Jones David Scott
2024-01-25 Sale -5044.00 Lurker Nancy
2024-01-24 Sale -28750.00 Jones David Scott
2023-12-07 Sale -733758.00 Ocumension Therapeutics
2023-12-07 Sale -733758.00 Liu Ye

SEC Filings


Form Type Description Pages Date
4 Insider transactions 1 Nov 12, 2025
8-k 8K-related 14 Nov 06, 2025
10-q Quarterly Reports 77 Nov 06, 2025
8-k 8K-related 12 Nov 05, 2025
8-k 8K-related 20 Oct 17, 2025
8-k 8K-related 42 Oct 14, 2025
4 Insider transactions 1 Sep 22, 2025
10-q Quarterly Reports 74 Aug 07, 2025
8-k 8K-related 12 Aug 06, 2025
8-k/a 8K-related 39 Jul 29, 2025

Latest News


× Before browsing our site, please accept our cookies policy